Annual EBIT
-$15.27 M
+$13.96 M+47.75%
June 30, 2024
Summary
- As of February 26, 2025, IBIO annual earnings before interest & taxes is -$15.27 million, with the most recent change of +$13.96 million (+47.75%) on June 30, 2024.
- During the last 3 years, IBIO annual EBIT has risen by +$5.49 million (+26.44%).
- IBIO annual EBIT is now -817.07% below its all-time high of -$1.67 million, reached on June 30, 2007.
Performance
IBIO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$4.31 M
-$375.00 K-9.54%
December 31, 2024
Summary
- As of February 26, 2025, IBIO quarterly earnings before interest & taxes is -$4.31 million, with the most recent change of -$375.00 thousand (-9.54%) on December 31, 2024.
- Over the past year, IBIO quarterly EBIT has dropped by -$375.00 thousand (-9.54%).
- IBIO quarterly EBIT is now -593.92% below its all-time high of $872.00 thousand, reached on June 30, 2011.
Performance
IBIO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$14.01 M
+$147.00 K+1.04%
December 31, 2024
Summary
- As of February 26, 2025, IBIO TTM earnings before interest & taxes is -$14.01 million, with the most recent change of +$147.00 thousand (+1.04%) on December 31, 2024.
- Over the past year, IBIO TTM EBIT has increased by +$147.00 thousand (+1.04%).
- IBIO TTM EBIT is now -3621.57% below its all-time high of -$376.40 thousand, reached on September 30, 2007.
Performance
IBIO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IBIO EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +47.8% | -9.5% | +1.0% |
3 y3 years | +26.4% | -9.5% | +1.0% |
5 y5 years | +2.7% | -9.5% | +1.0% |
IBIO EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +48.3% | -66.7% | +59.1% | at high | +60.2% |
5 y | 5-year | -9.3% | +48.3% | -692.4% | +59.1% | -0.2% | +60.2% |
alltime | all time | -817.1% | +48.3% | -593.9% | +59.1% | -3621.6% | +60.2% |
IBio EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | - | -$4.31 M(+9.5%) | -$14.01 M(-1.0%) |
Sep 2024 | - | -$3.93 M(+23.4%) | -$14.15 M(-7.3%) |
Jun 2024 | -$15.27 M(-47.8%) | -$3.19 M(+23.3%) | -$15.27 M(-10.2%) |
Mar 2024 | - | -$2.58 M(-42.0%) | -$17.00 M(-17.7%) |
Dec 2023 | - | -$4.45 M(-11.8%) | -$20.66 M(-22.7%) |
Sep 2023 | - | -$5.05 M(+2.7%) | -$26.74 M(-8.5%) |
Jun 2023 | -$29.23 M(-1.0%) | -$4.92 M(-21.3%) | -$29.23 M(-15.8%) |
Mar 2023 | - | -$6.24 M(-40.7%) | -$34.70 M(-1.4%) |
Dec 2022 | - | -$10.53 M(+39.7%) | -$35.20 M(+10.5%) |
Sep 2022 | - | -$7.54 M(-27.4%) | -$31.86 M(+7.8%) |
Jun 2022 | -$29.51 M(+42.2%) | -$10.39 M(+54.0%) | -$29.55 M(+60.3%) |
Mar 2022 | - | -$6.75 M(-6.2%) | -$18.43 M(-1.6%) |
Dec 2021 | - | -$7.19 M(+37.6%) | -$18.74 M(-1.7%) |
Sep 2021 | - | -$5.22 M(-818.7%) | -$19.06 M(-8.2%) |
Jun 2021 | -$20.76 M(+48.5%) | $727.00 K(-110.3%) | -$20.76 M(-15.0%) |
Mar 2021 | - | -$7.05 M(-6.2%) | -$24.41 M(+14.0%) |
Dec 2020 | - | -$7.52 M(+8.6%) | -$21.42 M(+25.6%) |
Sep 2020 | - | -$6.92 M(+136.6%) | -$17.05 M(+22.0%) |
Jun 2020 | -$13.98 M(-11.0%) | -$2.92 M(-28.0%) | -$13.98 M(-7.3%) |
Mar 2020 | - | -$4.06 M(+28.9%) | -$15.08 M(+2.1%) |
Dec 2019 | - | -$3.15 M(-18.1%) | -$14.77 M(-5.4%) |
Sep 2019 | - | -$3.84 M(-4.6%) | -$15.62 M(-0.5%) |
Jun 2019 | -$15.70 M(+10.6%) | -$4.03 M(+7.5%) | -$15.70 M(+0.6%) |
Mar 2019 | - | -$3.75 M(-6.1%) | -$15.61 M(+1.7%) |
Dec 2018 | - | -$3.99 M(+1.8%) | -$15.34 M(+3.9%) |
Sep 2018 | - | -$3.92 M(-0.4%) | -$14.77 M(+4.1%) |
Jun 2018 | -$14.19 M(-0.1%) | -$3.94 M(+13.1%) | -$14.19 M(+0.7%) |
Mar 2018 | - | -$3.48 M(+1.9%) | -$14.10 M(-3.0%) |
Dec 2017 | - | -$3.42 M(+2.2%) | -$14.54 M(+0.8%) |
Sep 2017 | - | -$3.35 M(-13.0%) | -$14.43 M(+1.5%) |
Jun 2017 | -$14.21 M(+44.3%) | -$3.85 M(-1.9%) | -$14.21 M(+8.5%) |
Mar 2017 | - | -$3.92 M(+18.6%) | -$13.10 M(+7.0%) |
Dec 2016 | - | -$3.31 M(+5.8%) | -$12.24 M(+9.5%) |
Sep 2016 | - | -$3.13 M(+14.3%) | -$11.17 M(+13.3%) |
Jun 2016 | -$9.85 M | -$2.74 M(-10.6%) | -$9.86 M(+9.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | -$3.06 M(+36.3%) | -$9.05 M(+18.1%) |
Dec 2015 | - | -$2.25 M(+23.9%) | -$7.66 M(+8.2%) |
Sep 2015 | - | -$1.81 M(-5.9%) | -$7.08 M(+5.9%) |
Jun 2015 | -$6.67 M(+73.6%) | -$1.93 M(+14.8%) | -$6.68 M(+13.1%) |
Mar 2015 | - | -$1.68 M(+0.7%) | -$5.91 M(+6.9%) |
Dec 2014 | - | -$1.67 M(+17.7%) | -$5.53 M(+0.5%) |
Sep 2014 | - | -$1.42 M(+23.0%) | -$5.50 M(+43.1%) |
Jun 2014 | -$3.84 M(-37.1%) | -$1.15 M(-11.1%) | -$3.84 M(-3.1%) |
Mar 2014 | - | -$1.29 M(-20.9%) | -$3.96 M(-10.2%) |
Dec 2013 | - | -$1.64 M(-781.7%) | -$4.41 M(+15.2%) |
Sep 2013 | - | $240.00 K(-118.8%) | -$3.83 M(-37.3%) |
Jun 2013 | -$6.11 M(+8.8%) | -$1.27 M(-26.9%) | -$6.11 M(-1.1%) |
Mar 2013 | - | -$1.74 M(+65.4%) | -$6.18 M(-17.8%) |
Dec 2012 | - | -$1.05 M(-48.2%) | -$7.51 M(-6.6%) |
Sep 2012 | - | -$2.04 M(+51.5%) | -$8.04 M(-3.5%) |
Jun 2012 | -$5.61 M(-41.9%) | -$1.34 M(-56.4%) | -$8.33 M(+36.2%) |
Mar 2012 | - | -$3.08 M(+94.9%) | -$6.11 M(+0.9%) |
Dec 2011 | - | -$1.58 M(-32.0%) | -$6.06 M(-34.0%) |
Sep 2011 | - | -$2.33 M(-366.6%) | -$9.17 M(-5.0%) |
Jun 2011 | -$9.65 M(+110.3%) | $872.00 K(-128.8%) | -$9.65 M(-20.8%) |
Mar 2011 | - | -$3.02 M(-35.6%) | -$12.19 M(+13.3%) |
Dec 2010 | - | -$4.70 M(+67.5%) | -$10.76 M(+68.9%) |
Sep 2010 | - | -$2.80 M(+68.4%) | -$6.37 M(+24.7%) |
Jun 2010 | -$4.59 M(+140.8%) | -$1.67 M(+4.6%) | -$5.11 M(+31.0%) |
Mar 2010 | - | -$1.59 M(+420.5%) | -$3.90 M(+48.0%) |
Dec 2009 | - | -$306.10 K(-80.2%) | -$2.63 M(-9.2%) |
Sep 2009 | - | -$1.54 M(+237.9%) | -$2.90 M(+52.2%) |
Jun 2009 | -$1.91 M(+2.2%) | -$456.90 K(+39.4%) | -$1.91 M(-18.3%) |
Mar 2009 | - | -$327.70 K(-42.7%) | -$2.33 M(-7.1%) |
Dec 2008 | - | -$571.50 K(+4.0%) | -$2.51 M(+9.5%) |
Sep 2008 | - | -$549.60 K(-37.8%) | -$2.29 M(+8.2%) |
Jun 2008 | -$1.87 M(+12.0%) | -$883.20 K(+74.6%) | -$2.12 M(+71.5%) |
Mar 2008 | - | -$505.80 K(+43.0%) | -$1.24 M(+69.3%) |
Dec 2007 | - | -$353.70 K(-6.0%) | -$730.10 K(+94.0%) |
Sep 2007 | - | -$376.40 K | -$376.40 K |
Jun 2007 | -$1.67 M | - | - |
FAQ
- What is iBio annual earnings before interest & taxes?
- What is the all time high annual EBIT for iBio?
- What is iBio annual EBIT year-on-year change?
- What is iBio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for iBio?
- What is iBio quarterly EBIT year-on-year change?
- What is iBio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for iBio?
- What is iBio TTM EBIT year-on-year change?
What is iBio annual earnings before interest & taxes?
The current annual EBIT of IBIO is -$15.27 M
What is the all time high annual EBIT for iBio?
iBio all-time high annual earnings before interest & taxes is -$1.67 M
What is iBio annual EBIT year-on-year change?
Over the past year, IBIO annual earnings before interest & taxes has changed by +$13.96 M (+47.75%)
What is iBio quarterly earnings before interest & taxes?
The current quarterly EBIT of IBIO is -$4.31 M
What is the all time high quarterly EBIT for iBio?
iBio all-time high quarterly earnings before interest & taxes is $872.00 K
What is iBio quarterly EBIT year-on-year change?
Over the past year, IBIO quarterly earnings before interest & taxes has changed by -$375.00 K (-9.54%)
What is iBio TTM earnings before interest & taxes?
The current TTM EBIT of IBIO is -$14.01 M
What is the all time high TTM EBIT for iBio?
iBio all-time high TTM earnings before interest & taxes is -$376.40 K
What is iBio TTM EBIT year-on-year change?
Over the past year, IBIO TTM earnings before interest & taxes has changed by +$147.00 K (+1.04%)